Synthesis and preclinical evaluation of a 68Ga-radiolabeled peptide targeting very late antigen-3 for PET imaging of pancreatic cancer

Pancreatic cancer is highly malignant, and has a five-year survival rate of 5% due to early lymph node, nerve and vascular metastasis. Integrin α3β1 (also called very late antigen-3, VLA-3) is over...